Antidilutive Securities, Name [Domain]
Antidilutive Security, Excluded EPS Calculation [Table]
Warrants [Member]
Warrant [Member]
Warrant [Member]
Reportable segment disclosed flag
Number Of Reportable Segments Not Disclosed Flag
Description of disclosed flag.
Operating segment
Number of Operating Segments
Segment Reporting [Table]
Segment Reporting [Abstract]
Chief executive officer description
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]
Segment description
Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description
Segment Reporting [Line Items]
Clinical trials
Clinical Trials
Represent the amount of clinical trials.
Stock based compensation
General And Administrative Stock Based Compensation
Represent the amount of general and administrative stock based compensation.
Schedule Of Consolidated Statements Of Operations Abstract
Schedule of Consolidated Statements of Operations [Line Items]
Other Operating Segment [Member]
Operating Segment [Member]
Other Operating Segment [Member]
Cost of revenues
Cost of revenues
Cost of Revenue, Total
Revenues from defense business
Revenues
Revenues, Total
Gross profit
Gross profit
Gross Profit, Total
Operating expenses:
Operating Expenses [Abstract]
Transaction costs
Sale of Stock, Consideration Received on Transaction
Shares issued and sold
Sale of Stock, Number of Shares Issued in Transaction
Cancelled shares of common stock
Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited
Segments [Domain]
Subsequent Events [Abstract]
Issuance of shares (in Shares)
Stock Issued During Period, Shares, Other
Subsequent Event Type [Axis]
Subsequent Event [Member]
Subsequent Event [Member]
Percentage of purchase
Percentage Of Purchase
Percentage of purchase.
Subsequent Events (Details) [Table]
Segments [Axis]
Depreciation expenses
Selling, General and Administrative Expense
Other segment items
Segment Reporting, Other Segment Item, Amount
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Table]
Geographical [Domain]
United States [Member]
UNITED STATES
Total
Long-Lived Asset, Excluding Financial Instrument, Customer Relationship, Mortgage Servicing Right, Deferred Policy Acquisition Cost, and Deferred Tax Asset, Amount
Israel [Member]
ISRAEL
Schedule of Revenues From External Customers and Long Lived Assets [Line Items]
Schedule of Consolidated Balance Sheets [Line Items]
Principal amount (in Dollars)
Debt Instrument Principal Amount
Amount of principal amount.
Non-current Assets
Assets, Noncurrent [Abstract]
Total assets
Assets
Current Liabilities
Liabilities, Current [Abstract]
Document Information [Table]
Document Type
Document Transition Report
Entity Incorporation, State or Country Code
City Area Code
Entity Address, Address Line Two
Entity Address, State or Province
Title of 12(b) Security
Document Fiscal Year Focus
Entity Registrant Name
Entity Tax Identification Number
Other current assets
Total
Other Assets, Current
Net loss attributable to the Company’s stockholders
Net Income (Loss) Attributable to Company's Stockholders
Amount of net income loss company stockholders.
Interest expense - related parties
Interest Expense Related Parties, Nonoperating
Amount of non operating interest expense related parties.
Amendment Flag
Entity Central Index Key
Current Fiscal Year End Date
Document Fiscal Period Focus
Entity File Number
Entity Emerging Growth Company
Entity Small Business
Entity Current Reporting Status
Assets
Assets:
Assets [Abstract]
Cash and cash equivalents
Cash and Cash Equivalent
Property and equipment, held for sale
Real Estate, Land, Held-for-Sale
Total non-current liabilities
Liabilities, Noncurrent
Stockholders’ equity (deficit)
Equity, Attributable to Parent [Abstract]
Day one loss upon entering transaction
Day One Loss Upon Entering Transaction
Represents the amount of loss upon entering transaction.
Balance due to Biomx Ltd
Other Notes Payable, Current
Other account payables
Accounts Payable, Other, Current
Non-current Liabilities
Liabilities, Noncurrent [Abstract]
Preferred Stock, $0.0001 par value; Authorized - 1,000,000 shares as of June 30, 2026 and December 31, 2025. Issued and outstanding – 51,598 as of June 30, 2026 and 147,512 shares as of December 31, 2025.
Preferred Stock, Value, Issued
Receivables on account of shares
Receivable from Shareholders or Affiliates for Issuance of Capital Stock
Accumulated deficit
Accumulated deficit
Retained Earnings (Accumulated Deficit)
Total liabilities and Stockholders’ equity (deficiency)
Liabilities and Equity
Statement of Financial Position [Abstract]
Preferred stock, shares authorized (in Shares)
Preferred stock, shares authorized
Preferred Stock, Shares Authorized
Preferred stock, shares outstanding (in Shares)
Preferred Stock, Shares Outstanding
Common stock, shares authorized (in Shares)
Common Stock, Shares Authorized
Common stock, shares outstanding (in Shares)
Common Stock, Shares, Outstanding
Loss (income) from change in derivatives financial instruments measured at fair value
Income/loss from change in fair value of warrants
Income/loss from change in fair value of warrants.
Document Information [Line Items]
Document Quarterly Report
Entity Interactive Data Current
Entity Address, Postal Zip Code
Local Phone Number
Entity Address, Address Line One
Entity Address, City or Town
Entity Common Stock, Shares Outstanding
Security Exchange Name
Trading Symbol
Entity Filer Category
Entity Shell Company
Current Assets
Assets, Current [Abstract]
Restricted cash
Restricted Cash, Current
Warrant liability issued as consideration for subsidiary acquisition
Warrant Liability Issued As Consideration For Subsidiary Acquisition Current
Represent the amount of warrant liability issued as consideration for subsidiary acquisition current.
Promissory notes
Promissory Notes Current
Represent the amount of promissory notes current.
Research and development (“R&D”) expenses, net
Amount of research and development (“R&D”) expenses, net.
Issuance of Series Y Convertible Preferred Stock (in Shares)
Series convertible preferred stock
Stock Issued During Period, Shares, Conversion of Convertible Securities
Diluted loss per share of Common Stock (in Dollars per share)
Diluted loss per share of common stock (in Dollars per share)
Earnings Per Share, Diluted
Class of Stock [Domain]
RECONCILIATION OF AMOUNTS ON CONSOLIDATED BALANCE SHEETS
Cash and Cash Equivalents [Abstract]
Taxes paid
Income Tax Paid, after Refund Received
Accrued Preferred dividends on Series Y Convertible Preferred Stock
Redeemable Convertible Preferred Share Conversion Into Shares Of Common Stock
Represents the amount of redeemable convertible preferred shares conversion into shares of common stock.
Effect of exchange rate changes on cash and cash equivalents
Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Net loss
Net loss
Net loss
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total
Comprehensive loss:
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Net loss attributable to non-controlling interests
Net Income (Loss) Attributable to Noncontrolling Interest
Other comprehensive income (loss) attributable to non-controlling interests -foreign currency translation adjustments
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Noncontrolling Interest
Stock-based compensation expenses (in Shares)
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture
Issuance of shares for investment in Zorronet
Issuance of Shares for Investment in Zorronet
Issuance of Shares for Investment in Zorronet.
Issuance of shares for investment in Zorronet (in Shares)
Issuance of Shares for Investment in Zorronet Shares
Issuance of Shares for Investment in Zorronet Shares.
Changes in balance of severance pay fund
Increase Decrease in Balance of Severance Pay Fund
The amount of changes in balance of severance pay fund.
Statement [Table]
Statement [Line Items]
Issuance of warrants and shares for investment in DFSL
Issuance of Warrants and Shares for Investment in Dfsl
Issuance of Warrants and Shares for Investment in Dfsl.
Decrease (increase) in trade receivables
Increase (Decrease) in Receivables, Total
Issuance of warrants and shares for investment in DFSL (in Shares)
Issuance of Warrants and Shares for Investment in Dfsl Shares
Issuance of Warrants and Shares for Investment in Dfsl Shares.
Issuance of shares as partial payment of promissory note
Issuance of Shares as Partial Payment of Promissory Note
Issuance of Shares as Partial Payment of Promissory Note.
Issuance of shares as partial payment of promissory note (in Shares)
Issuance of Shares as Partial Payment of Promissory Note Shares
Issuance of Shares as Partial Payment of Promissory Note Shares.
Issuance of Common Stock under At the Market Sales Agreement, net of $ 39 issuance costs
Issuance of Common Stock Under at the Market Sales Agreement
Issuance of Common Stock Under at the Market Sales Agreement.
Issuance of Common Stock under At the Market Sales Agreement, net of $ 39 issuance costs (in Shares)
Issuance of Common Stock Under at the Market Sales Agreement Shares
Issuance of Common Stock Under at the Market Sales Agreement Shares.
Subsidiaries consolidation for the first time
Subsidiaries Consolidation for the First Time
Subsidiaries Consolidation for the First Time.
Expected dividend yield [Member]
Measurement Input, Expected Dividend Rate [Member]
Expected term (years) [Member]
Expected Terms [Member]
Measurement Input, Expected Term [Member]
Conversion price (U.S. dollars) [Member]
Measurement Input, Conversion Price [Member]
Underlying share price (U.S. dollars) [Member]
Share Price [Member]
Measurement Input, Share Price [Member]
Fair value (U.S. dollars in thousands) [Member]
Measurement Input Fair Value [Member]
Warrants and Rights Outstanding, Measurement Input
Fair values of liabilities
Transaction During The Period [Table]
Transaction During the Period [Line Items]
Related Party Transaction [Line Items]
Percentage of issued and outstanding
Percentage Of Issued And Outstanding
Percentage of issued and outstanding.
Cash payment (in Dollars)
Payments to Acquire Businesses, Net of Cash Acquired
Common stock, par value (in Dollars per share)
Common Stock, Par or Stated Value Per Share
Conversion price (in Dollars per share)
Debt Instrument Convertible Conversion Price Per Share
Amount of Conversion price.
Exercise price per share (in Dollars per share)
Exercise Price Per Share
Exercise price per share
Class of Warrant or Right, Exercise Price of Warrants or Rights
Expiration term
Warrants and Rights Outstanding, Term
Annual revenues (in Dollars)
Annual Revenues
Amount of annual revenues.
Percentage of annual revenues
Perentage Of Annual Revenues
Perentage of annual revenues.
Trading days
Trading Days
Trading days.
Non-convertible promissory note (in Dollars)
Non Convertible Promissory Note
Amount of Non-convertible promissory note.
Class of Warrant or Right [Axis]
Class of Warrant or Right [Domain]
Pre-Funded Warrants [Member]
Pre Funded Warrant Member
Five Year Warrant [Member]
Five Year Warrant Member
Completion days
Completion Days
Completion days.
Total consideration
Lines of Credit, Fair Value Disclosure
Revaluation of contingent consideration
Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease)
Loss from sale and disposal of fixed assets, net
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property
Operating loss
Operating Income (Loss)
Tax expenses
Income Tax Expense (Benefit)
Basic loss per share of Common Stock (in Dollars per share)
Basic loss per share of common stock (in Dollars per share)
Earnings Per Share, Basic
Finance expense, net
Other Nonoperating Income (Expense)
Series Y Redeemable Convertible
Series YRedeemable Convertible Preferred Shares Member
Redeemable Convertible Preferred Shares
Redeemable Convertible Preferred Shares Member
Weighted average number of shares used in computing basic loss per share of Common Stock (in Shares)
Weighted Average Number of Shares Outstanding, Basic
Decrease in cash as a result of deconsolidation of subsidiary
Decrease In Cash As AResult Of Deconsolidation Of Subsidiary
Decrease in cash as a result of deconsolidation of subsidiary.
Changes in operating assets and liabilities:
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]
Trade accounts payable
Increase (Decrease) in Accounts Payable, Trade
Income Statement [Abstract]
Net gain from deconsolidation of subsidiary
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Noncontrolling Interest
Reclassification of embedded conversion derivative upon conversion of Series Y Convertible Preferred Stock
Reclassification Of Embedded Conversion Derivative Upon Conversion Of Series Y Convertible Preferred Stock
The amount of reclassification of embedded conversion derivative upon conversion of series Y convertible preferred stock.
Conversion of Series Y Convertible Preferred Stock into common stock
Conversion Of Series YConvertible Preferred Stock Into Common Stock
Conversion of series Y convertible preferred stock into common stock.
Preferred Shares
Preferred Stock [Member]
Preferred Stock [Member]
Additional paid-in capital
Additional Paid-in Capital [Member]
Other comprehensive income (loss) - Foreign currency translation adjustments
Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax
Debt Instrument [Axis]
Debt Instrument, Name [Domain]
Convertible Promissory Note [Member]
Water IO [Member]
Class of Stock [Axis]
Common Stock [Member]
Common Stock [Member]
Common stock
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Option and Undertaking Agreement [Member]
Stock Purchase & Assignment Agreement [Member]
Percentage of warrant beneficial ownership limitation
Percentage Of Warrant Beneficial Ownership Limitation
Percentage of warrant beneficial ownership limitation.
Initial term
Initial Term Of The Agreement
Initial term of the agreement.
Extend term
Extend Term Of The Agreement
Extend term of the agreement.
Number of days prior written notice
Number Of Days Prior Written Notice
Number of days prior written notice.
Number of days invoice submission
Number Of Days Invoice Submission
Number of days invoice submission.
Equity investment
Equity Investment Amount
Equity investment amount.
Percentage of equity investment
Percentage Of Equity Investment
Percentage of equity investment.
Percentage of interest in post investment basis
Percentage Of Interest In Post Investment Basis
Percentage of interest in post investment basis.
Credit facility maximum amount
Line of Credit Facility, Maximum Amount Outstanding During Period
Day one loss upon entering transaction
Adjustment Of Day One Loss Upon Entering Transactios
Represent the amount of day one loss upon entering transaction.
Issuance of Series Y Convertible Preferred Stock
Stock Issued During Period, Value, Conversion of Convertible Securities
Preferred dividends on Series Y Convertible Preferred Stock
Adjustments To Additional Paid In Capital Preferred Dividends On Series YConvertible Preferred Stock
Amount of preferred dividends on series y convertible preferred stock.
Offset of promissory note
Offset of promissory note Receivable On Account Of Shares
It represents Offset of promissory note into receivables on account of shares.
Subsequent Event Type [Domain]
Business Combination [Axis]
Business Combination [Domain]
DFSL [Member]
DR. Frucht Systems Ltd [Member]
Percentage of acquisitions
Business Combination, Voting Equity Interest Acquired, Percentage
Percentage of call arrangements over the remaining
Percentage of Call Arrangements Over the Remaining
Represent the percentage of call arrangements over the remaining.
Enterprise value
Enterprise Value
Represent the amount of enterprise value.
Issuance Date
Class of Warrant or Right, Date from which Warrants or Rights Exercisable
Stockholders Equity - Schedule of Options Granted to Purchase the Company’s Common Stock Under the Company’s Share Option Plans (Details) [Table]
Goodwill
Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]
Revenue recognition
Revenue from Contract with Customer [Policy Text Block]
Stock purchase warrants
Stock purchase warrants [Policy Text Block]
Disclosure of accounting policies for stock purchase warrants.
Series X Preferred Stock [Member]
ZorroNet [Member]
Date of incorporation
Entity Incorporation, Date of Incorporation
Percentage of shares issued and outstanding
Percentage Of Common Stock Total Shares Issued And Outstanding
Percentage of Common Stock total shares issued and outstanding
Remaining amount of promissory note
Remaining Amount of Promissory Note
The remaining amount of promissory note.
Purchase of aggregate shares
Purchase of Aggregate Shares
Number of purchase an aggregate of shares.
Series X Conversion and A&R Warrant Exercise [Member]
Common shares issued
Common stock, $0.0001 par value (“Common Stock”); Authorized - 750,000,000 shares as of June 30, 2026 and December 31, 2025. Issued and outstanding – 12,590,640 and 1,593,703 as of June 30, 2026 and December 31, 2025, respectively.
Common Stock, Value, Issued
Common shares for net of issuance costs
Issuance of Common Stock under Inducement Letter Agreements
Issuance Of Common Stock Under Open Market Sales Agreement Net Of Issuance Costs
Issuance of Common Stock under Open Market Sales Agreement, net of issuance costs.
Prepaid transaction expenses and placement agent fee
Net of issuance costs
Payments of Stock Issuance Costs
Preferred stock, shares issued
Preferred stock, shares issued (in Shares)
Preferred Stock, Shares Issued
Investors gross proceeds (in Dollars)
Investors Gross Proceeds
Investors gross proceeds.
Purchase of warrants (in Dollars)
Warrants
Warrants and Rights Outstanding
Received gross proceeds
Proceeds from issuance of preferred share and warrants under January 2026 private placement, net of issuance costs
Proceeds from Issuance of Private Placement
Initial conversion price (in Dollars per share)
Common Stock, Convertible, Conversion Price, Increase
Ownership limitations
Equity Method Investment, Ownership Percentage
Pre-funded warrants
Prefunded Warrants
Pre-funded warrants.
Warrants issued
Number of Shares of Common Stock Underlying Warrants
Class of Warrant or Right, Outstanding
Reduce exercise price of the warrant (in Dollars per share)
Warrant, Exercise Price, Decrease
Warrant liability (in Dollars)
Change in terms of warrant liability
Fair Value Adjustment of Warrants
Aggregate gross proceeds (in Dollars)
Issuance of Common Stock under February 2025 SPA
Proceeds from Issuance of Common Stock
Percentage of maximum of volatility rate
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum
Stockholders' Equity [Line Items]
Stockholders Equity [Line Items]
Preferred stock, par value (in Dollars per share)
Preferred Stock, Par or Stated Value Per Share
A&R Warrants [Member]
ARWarrants Member
Equity Component [Domain]
Percentage of risk free rate minimum
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum
Derivative at issuance (in Dollars)
Payments of Derivative Issuance Costs
CASH FLOWS FROM FINANCING ACTIVITIES:
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]
Issuance of Common Warrants under February 2025 SPA
Proceeds from Issuance of Warrants
Net cash provided by financing activities
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Restricted cash
Restricted Cash
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Supplemental Cash Flow Elements [Abstract]
General (Details) [Table]
Equity Components [Axis]
Investment in short term securities - net
Payments to Acquire Equity Securities, FV-NI
Cash used in purchase of subsidiaries, net
Payments to Acquire Interest in Subsidiaries and Affiliates, Total
Short-term bank credit
Proceeds from (Repayments of) Lines of Credit
Pre-Funded Warrants and Common Warrants exercise
Proceeds from Warrant Exercises
Loss of transaction amount
Loss Of Transaction Amount
Represents the amount of loss upon entering transaction.
Deconsolidation of Biomx Ltd [Abstract]
Stockholders' Equity [Table]
Stockholders Equity (Details) [Table]
Series Y Convertible Preferred Stock [Member]
Series YConvertible Preferred Stock Member
Statistical Measurement [Axis]
Maximum [Member]
Maximum [Member]
Securities Purchase Agreement [Member]
Securities Purchase Agreement Member
Related and Nonrelated Parties [Domain]
Share Option [Member]
Equity Option [Member]
Number of Options, Outstanding at the end of period
Number of Options, Outstanding at the beginning of period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Aggregate Intrinsic Value, Outstanding at the end of period
Aggregate Intrinsic Value, Outstanding at the beginning of period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Weighted Average Exercise Price,Exercisable at end of period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]
StatementOfIncomesLocationBalanceDomain [Domain]
Schedule of Basic and Diluted Net Loss Per Share
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
General [Abstract]
Number of shares received
Issuance of common stock
Stock Issued During Period, Shares, New Issues
Reverse stock split
Stockholders' Equity, Reverse Stock Split
Fair Value Measurements [Abstract]
Net gain from discontinued operations
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Stockholders' Equity [Abstract]
Basic and Diluted Loss Per Share - Schedule of Diluted Loss Per Share (Details) [Line Items]
CASH FLOWS FROM OPERATING ACTIVITIES:
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]
Stock-based compensation
Share-Based Payment Arrangement, Noncash Expense
Unaudited Condensed Financial Statements
Basis of Presentation and Significant Accounting Policies [Text Block]
DECONSOLIDATION OF BIOMX LTD
Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]
Issuance of Common Warrants
Proceeds from Other Equity
Exercise of warrants into common stock
Exercise Of Warrants Into Common Stock
Exercise of warrants into common stock.
Change in fair value
Fair Value, Option, Changes in Fair Value, Gain (Loss)
Use of estimates in the preparation of financial statements
Use of Estimates, Policy [Policy Text Block]
Schedule of Fair Value of Liabilities for Warrants [Abstract]
Minimum [Member]
Minimum [Member]
Exercise Price [Member]
Measurement Input, Exercise Price [Member]
Fair Value Hierarchy and NAV [Axis]
Measurement Input Type [Axis]
Other Account Payables [Abstract]
Accrued expenses
Accrued Liabilities, Current
Total
Accounts Payable, Other
Schedule of Carrying Amounts of Assets and Liabilities [Abstract]
Other current assets
Disposal Group, Including Discontinued Operation, Other Assets, Current
Total assets
Disposal Group, Including Discontinued Operation, Assets
Basic and Diluted Loss Per Share [Abstract]
SEGMENT REPORTING
Segment Reporting [Text Block]
Series Y Preferred Stock [Member]
Series YPreferred Stock Member
Weighted Average Exercise Price, Granted
Exercise price, granted (in Dollars per share)
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Weighted Average Exercise Price, Forfeited
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
Weighted Average Exercise Price, Expired
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price
Weighted Average Exercise Price, Exercised
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Weighted Average Exercise Price, Outstanding at the end of period
Weighted Average Exercise Price, Outstanding at the beginning of period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Number of Options, Exercisable at end of period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Number of Options, Weighted average remaining contractual life – years
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted-Average Remaining Contractual Term
Fair Value Hierarchy and NAV [Domain]
Derivative Contract [Domain]
Short-Term Debt, Type [Axis]
Short-Term Debt, Type [Domain]
Promissory Note [Member]
Proceeds from related party loan
Proceeds from Related Party Debt
Purchase of fixed assets
Payments to Acquire Productive Assets, Total
Warrant liability issued as consideration for subsidiary acquisition
Warrant Liability Issued As Consideration For Subsidiary Acquisition
Represent the amount of warrant liability issued as consideration for subsidiary acquisition.
Schedule of Financial Assets that are Measured at Fair Value on Recurring Basis by Level
Fair Value, Assets Measured on Recurring Basis [Table Text Block]
Schedule of Fair Value of Liabilities for Warrants
Schedule Of Main Assumptions Table Text Block
Tabular disclosure of main assumptions.
Other Current Assets [Abstract]
Schedule of Other Account Payables
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]
Schedule of Consolidated Statements of Operations
Segment Reporting, Reconciliation of Revenue by Segment to Consolidated [Table Text Block]
Fair Value Measurements - Schedule of Financial Assets that are Measured at Fair Value on a Recurring Basis by Level [Table]
Fair Value Measurements - Schedule of Financial Assets that are Measured at Fair Value on a Recurring Basis by Level (Details) [Table]
Measurement Frequency [Domain]
Level 1 [Member]
Fair Value, Inputs, Level 1 [Member]
Level 3 [Member]
Level 3 [Member]
Fair Value, Inputs, Level 3 [Member]
Money market funds
Cash Equivalent, Money Market Fund, Carrying Value
Liabilities:
Liabilities [Abstract]
Total liabilities
Long term liabilities
Liabilities, Fair Value Disclosure
Schedule of Fair Value of Level 3 Liabilities [Abstract]
Schedule of Fair Value of Level 3 Liabilities [Line Items]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Common Warrants [Member]
Common Warrants Member
Landlord Warrants [Member]
Landlord Warrants Member
January 2026 private placement agent warrants [Member]
January Two Thousand Twenty Six Private Placement Agent Warrants Member
Schedule of Options Granted to Purchase the Company’s Common Stock Under the Company’s Share Option Plans
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
Common Stock Issued to Stockholders [Member]
Common Stock Issued To Stockholders Member
Schedule of Outstanding Warrants to Purchase Common Stock Issued to Stockholders [Line Items]
Expiration Date
Warrants and Rights Outstanding, Maturity Date
Schedule Of Options Granted To Purchase The Company SCommon Stock Under The Company SShare Option Plans Abstract
Derivative Instrument [Axis]
Schedule of Options Granted to Purchase the Company’s Common Stock Under the Company’s Stock Option Plans [Line Items]
Schedule of Fair Value of Warrant Option [Line Items]
Contingent shares [Member]
Contingent Shares Member
Options [Member]
Options Member
Redeemable Convertible Preferred Shares [Member]
Redeemable Convertible Preferred Share Member
Schedule Of Diluted Loss Per Share Effect Of Anti Dilutive Abstract
Diluted loss per share effect of anti-dilutive
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Antidilutive Securities [Axis]
Schedule of Diluted Loss Per Share Effect of Anti-Dilutive [Line Items]
Basic and Diluted Loss Per Share [Line Items]
Salaries and related expenses, other than share-based compensation
Goodwill, Impairment Loss
Insurance
General Insurance Expense
Total Operating loss
Operating Expenses
Schedule of Revenues From External Customers and Long Lived Assets [Abstract]
Geographical [Axis]
Restricted shares of common stock
Restricted shares of common stock.
Accrued interest
Accounts Receivable, Allowance for Credit Loss, Excluding Accrued Interest, Noncurrent
Purchase of shares
Purchase of shares.
Mayers payment
Mayers payment.
Percentage of issued share capital
Percentage of issued share capital.
Subsequent Events [Line Items]
Document Period End Date
Short term investments
Short-Term Investments, Total
Trade receivables
Accounts Receivable, after Allowance for Credit Loss, Current
Property and Equipment, Net
Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization, Total
Right Of Use asset arising from operating lease and deposits
Operating Lease, Right-of-Use Asset
Goodwill & intangible assets
Amount of goodwill & intangible assets.
Funds in respect of employee rights upon terminations
Funds in Respect of Employee Rights Upon Terminations
Amount of funds in respect of employee rights upon terminations.
Total Non-current assets
Assets, Noncurrent, Total
Loans payable - related parties
Loans Payable, Current, Total
Contingent consideration
Amount of contingent consideration.
Short term bank credit
Short-Term Debt, Total
Long term loans, net of current portion
Long-Term Debt, Excluding Current Maturities, Total
Right Of Use liabilities arising from operating lease
Operating Lease, Liability, Noncurrent
Severance pay liability
Amount of severance pay liability.
Foreign currency translation adjustments
Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax
Non-controlling interests
Equity, Attributable to Noncontrolling Interest
Total Stockholders’ equity (deficit)
Balance
Balance
Equity, Including Portion Attributable to Noncontrolling Interest, Total
Related and Nonrelated Parties [Axis]
Related Party
Related Party [Member]
Total Current assets
Assets, Current
In-process Research and development (“IPR&D”) asset
Inprocess Research And Development Asset Non Current
Represents the amount of in-process research and development (“IPR&D”) asset, non-current portion.
Liabilities and Capital Deficiency
Liabilities and Equity [Abstract]
Trade account payables
Accounts Payable, Trade, Current
Current portion of lease liabilities
Operating Lease, Liability, Current
Total current liabilities
Liabilities, Current
Additional paid-in capital
Additional Paid in Capital
Total Company’s stockholders’ equity (deficit)
Equity, Attributable to Parent
Common stock, shares issued (in Shares)
Common Stock, Shares, Issued
Total liabilities
Liabilities
Cover [Abstract]
Foreign currency translation adjustments
Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent
Conversion of A&R Warrants
Conversion of A&R Warrants
Conversion of A&R Warrants.
Conversion of A&R Warrants (in Shares)
Conversion of A&R Warrants Shares
Conversion of A&R Warrants Shares.
Conversion of Series X Redeemable Convertible Preferred Shares
Conversion of Series X Redeemable Convertible Preferred Shares
Conversion of Series X Redeemable Convertible Preferred Shares.
Conversion of Series X Redeemable Convertible Preferred Shares (in Shares)
Conversion of Series X Redeemable Convertible Preferred Shares, Shares
Conversion of Series X Redeemable Convertible Preferred Shares, Shares.
Issuance of Common Stock under At the Market Sales Agreement, net of $39 issuance costs
Issuance of Common Stock under the Market Sales Agreement
The amount of issuance of common stock under at the market sales agreement.
Exercise of Private Pre-Funded Warrants and Common Warrants
Exercise of Private Pre-Funded Warrants and Common Warrants
Exercise of Private Pre-Funded Warrants and Common Warrants.
Exercise of Private Pre-Funded Warrants and Common Warrants (in Shares)
Exercise of Private Pre-Funded Warrants and Common Warrants Shares
Exercise of Private Pre-Funded Warrants and Common Warrants Shares.
Property and equipment purchases included in other accounts payable and trade accounts payable
Property and Equipment Purchases Included in Other Accounts Payable and Trade Accounts Payable
The amount of property and equipment purchases included in other accounts payable and trade accounts payable.
Issuance of Common Stock upon restricted stock units vesting
Issuance of Common Stock Upon Restricted Stock Units Vesting
Issuance of Common Stock Upon Restricted Stock Units Vesting.
Issuance of Common Stock upon restricted stock units vesting (in Shares)
Issuance of Common Stock Upon Restricted Stock Units Vesting Shares
Issuance of Common Stock Upon Restricted Stock Units Vesting Shares.
Statement of Cash Flows [Abstract]
Accumulated Other Comprehensive Income (Loss)
AOCI Attributable to Parent [Member]
Non-Controlling interests
Noncontrolling Interest [Member]
Receivables on account of shares
Receivables on Account of Shares [Member]
Transaction During the Period [Abstract]
Transaction During The Period [Abstract]
TRANSACTION DURING THE PERIOD
Related Party Transactions Disclosure [Text Block]
Schedule of Fair Value of Warrant Option
Fair Value Option, Disclosures [Table Text Block]
Schedule of Fair Value of Assets Acquired and Liabilities
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Common Warrant [Member]
Common Warrant [Member]
Goodwill and intangible assets
Goodwill, Fair Value Disclosure
Long terms assets
Property, Plant, and Equipment, Fair Value Disclosure
Net assets acquired
Fair Value, Net Asset (Liability), Total
Working capital
Working Capital Disclosure
Working Capital Disclosure
Non-controlling interest
Non-Controlling Interest
Non-Controlling Interest.
Measurement Input Type [Domain]
Expected volatility (%) [Member]
Measurement Input, Option Volatility [Member]
Risk-free interest rate (%) [Member]
Risk Free Interest Rate [Member]
Measurement Input, Risk Free Interest Rate [Member]
General and administrative expenses
General and Administrative Expense
Net loss before tax
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Net loss
Net loss
Other expenses (income)
Other Income
Interest expenses
Interest Expense, Nonoperating
Statement of Stockholders' Equity [Abstract]
Series X Redeemable Convertible
Series XRedeemable Convertible Preferred Shares Member
Fair value of promissory notes issued
Notes Payable, Fair Value Disclosure
Fair value of share issued
Contingent Consideration Classified as Equity, Fair Value Disclosure
Performance-based earnout payable
Performance Based Earnout Payable
Represent the amount of performance-based earnout payable.
Credit Facility [Axis]
Credit Facility [Domain]
Revolving Credit Facility [Member]
Revolving Credit Facility [Member]
Annual rate
Line of Credit Facility, Interest Rate at Period End
Outstanding principal amount
Long-Term Line of Credit, Total
Undrawn availability
Undrawn Availability Of Credit Facility
Represent the amount of undrawn availability of the credit facility.
Contractual term
Credit Facility Remaining Contractual Term
Credit facility remaining contractual term.
Expected volatility
Percentage Of Credit Facility Expected Volatility
Percentage of credit facility expected volatility.
INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD
Total cash and cash equivalents and restricted cash
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Cash paid for interest
Interest Paid, Excluding Capitalized Interest, Operating Activity
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES
Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]
Exercise of warrants into common stock
Conversion Of Warrants Into Common Stock
The amount of conversion of warrants into common stock.
Conversion of Series Y Convertible Preferred Stock into common stock
Stock Issued During Period, Value, Conversion of Units
Exercise of warrants into common stock
Stock Issued During Period Value Exercise Of Warrants Into Common Stock
Represents the amount of exercise of warrants into common stock.
Reclassification of embedded conversion derivative upon conversion of Series Y Convertible Preferred Stock
Adjustments To Additional Paid In Capita Reclassification Of Embedded Conversion Derivative Upon Conversion Of Series YConvertible Pre
The amount of reclassification of embedded conversion derivative upon conversion of Series Y convertible preferred stock.
Issuance of Common Stock, Registered Pre- Funded Warrants and Private Pre-Funded Warrants under the February 2025 SPA, net of issuance costs (in Shares)
Stock Issued During Period Shares Issuance Of Common Stock Under An Open Market Offering Agreement
Represents the number of stock issued under issuance of common stock under an open market offering agreement.
Issuance of Common Stock under Inducement Letter Agreements (in Shares)
Stock Issued During Period Shares Issuanceof Common Stockunder Inducement Letter Agreements
Number of shares issued during the period to issuance of common stock under the inducement letter agreements.
Balance (in Shares)
Balance (in Shares)
Shares, Outstanding
Depreciation
Depreciation
Loss (income) from change in fair value of liability-classified warrants
Income From Change In Fair Value Of Warrants
Income from change in fair value of warrants.
Gain from deconsolidation of subsidiary
Deconsolidation, Gain (Loss), Amount
Other current assets
Increase (Decrease) in Other Current Assets
Other accounts payable and current portion of lease liabilities
Increase (Decrease) in Other Accounts Payable
Net change in operating leases
Increase (Decrease) in Operating Lease Liability
Net - loss attributable to non-controlling interests
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest
Comprehensive loss attributable to the Company’s stockholders
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive loss
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest
Accumulated deficit
Retained Earnings [Member]
Conversion of Series Y Convertible Preferred Stock into common stock (in Shares)
Converted shares
Stock Issued During Period, Shares, Conversion of Units
Exercise of warrants into common stock (in Shares)
Stock Issued During Period Shares Exercise Of Warrants Into Common Stock
Number of shares issued during the period to exercise of warrants into common stock.
Issuance of Common Stock, Registered Pre- Funded Warrants and Private Pre-Funded Warrants under the February 2025 SPA, net of issuance costs
Stock Issued During Period Value Issuanceof Common Stockunderan Open Market Offeringand Sales Agreement
Value of shares issued during the period to issuance of common stock under an open market offering and sales agreement.
Issuance of Common Stock under Inducement Letter Agreements
Stock Issued During Period Value Issuanceof Common Stockunder Inducement Letter Agreements
Value of shares issued during the period to issuance of common stock under the inducement letter agreements.
Stock-based compensation expenses
Shares Granted, Value, Share-Based Payment Arrangement, after Forfeiture
Adjustments required to reconcile net loss for the period to net cash used in operating activities:
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Noncash Item [Abstract]
Cumulative sales
Cumulative Sales
Represent the amount of cumulative sales.
Closing enterprise value
Closing Enterprise Value
Represent the amount of closing enterprise value.
Percentage of interest applied pro rata
Percentage of Interest Applied Pro Rata
Represent the percentage of interest applied pro rata.
Number of material change to agreed business plan
Number of Material Change to Agreed Business Plan
Represent the number of material change to agreed business plan.
Percentage of sales target reduce
Percentage of Sales Target Reduce
Represent the percentage of sales target reduce.
Scenario [Axis]
Scenario [Domain]
Forecast [Member]
Put and call option expires
Put and Call Option Expires
Represent the put and call option expires.
Options exercised
Stock Issued During Period, Value, Stock Options Exercised
Percentage of revenue including a performance based earnout payable
Percentage of Revenue Including a Performance Based Earnout Payable
Represent the percentage of revenue including a performance based earnout payable.
Number of days to file a registration statement with the SEC
Number of Days to File a Registration Statement with the SEC
Represent the number of days to file a registration statement with the SEC.
Investment, Name [Axis]
January 2026 private placement agent warrants [Member]
January2026 Private Placement Agent Warrants Member
Aggregate gross proceeds (in Dollars)
Proceeds from Issuance Initial Public Offering
Convertible into shares of common stock (in Dollars)
Conversion of Stock, Amount Converted
Preferred stock at a rate
Preferred Stock, Dividend Rate, Percentage
Number of trading days
Number Of Trading Days Period Prior To Common Stock
Number of trading days period prior to common stock.
Stock converted
Convertible Preferred Stock, Shares Issued upon Conversion
Gross proceeds (in Dollars)
Gross Proceeds
The amount of gross proceeds.
Percentage of volatility rate
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum
Basic and Diluted Loss Per Share (Details) [Table]
Percentage of risk free rate
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum
Maturity time
Derivative, Remaining Maturity
Fair value (in Dollars)
Equity, Fair Value Adjustment
Schedule of Carrying Amounts of Assets and Liabilities
Disposal Groups, Including Discontinued Operations [Table Text Block]
Schedule of Revenues From External Customers and Long Lived Assets
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Table Text Block]
Schedule Of Financial Assets That Are Measured At Fair Value On ARecurring Basis By Level Abstract
Measurement Frequency [Axis]
Fair Value, Recurring [Member]
Fair Value, Recurring [Member]
Level 2 [Member]
Fair Value, Inputs, Level 2 [Member]
Schedule of Financial Assets that are Measured at Fair Value on Recurring Basis by Level [Line Items]
Fair Value Measurements - Schedule of Financial Assets that are Measured at Fair Value on a Recurring Basis by Level (Details) [Line Items]
Cash equivalents:
Cash and Cash Equivalent [Abstract]
Total assets
Assets, Fair Value Disclosure
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]
Beginning balance
Ending balance
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
Inducement Warrants [Member]
Inducement Warrants Member
Private Warrants issued to scientific founders [Member]
Private Warrants Issued To Scientific Founders Member
Agents Warrants [Member]
Agents Warrants Member
Schedule of Outstanding Warrants to Purchase Common Stock Issued to Stockholders
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
Schedule of Stock-Based Payment Expenses
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
Repayment of long-term loans
Repayments of Long-Term Debt, Total
Functional currency
Foreign Currency Transactions and Translations Policy [Policy Text Block]
Business Combinations
Business Combination [Policy Text Block]
Intangible assets
Intangible Assets, Finite-Lived, Policy [Policy Text Block]
Accounts receivables
Accounts Receivable [Policy Text Block]
Denominator:
Weighted Average Number of Shares Outstanding, Basic [Abstract]
Number of shares upon pre-funded warrants and A&R Warrants exercise
Number Of Shares Upon Prefunded Warrants And Aamp RWarrants Exercise
Number of shares upon pre-funded warrants and A&R warrants exercise.
Total weighted-average number of shares of common stock, shares upon pre-funded warrants, A&R Warrants and Fully vested Warrants exercise used in computing basic and diluted loss per share
Weighted Average Number of Shares Outstanding, Diluted
Redeemable Convertible Preferred Shares [Member]
Redeemable Convertible Preferred Stock [Member]
Statistical Measurement [Domain]
Net cash provided by (used in) investing activities
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
February 2025 SPA issuance costs
Payments of Debt Issuance Costs
GENERAL
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
Summary of Significant Accounting Policies and Basis of Presentation [Abstract]
FAIR VALUE MEASUREMENTS
Fair Value Disclosures [Text Block]
OTHER ACCOUNT PAYABLES
Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]
Basic and dilutedloss per share of common stock
Basic And Dilutedloss Per Share Of Common Stock Abstract
HC Wainwright & Co [Member]
HCWainwright Co Member
Investment, Name [Domain]
Finance income, net
Other Noncash Income (Expense)
Private Placement Warrants issuance cost
Issuance of Stock and Warrants for Services or Claims
Number of Options, Exercised
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period
CASH FLOWS FROM INVESTING ACTIVITIES:
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]
Proceeds from sale of property and equipment
Proceeds from Sale of Productive Assets
Schedule of Fair Value of Level 3 Liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
Schedule of Other Current Assets
Schedule of Other Current Assets [Table Text Block]
Schedule Of Stock Based Payment Expenses Abstract
Statement of Incomes Location, Balance [Axis]
Statement Of Incomes Location Balance Axis
Schedule of Diluted Loss Per Share Effect of Anti-Dilutive
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
BiomX Israel [Member]
Biom XIsrael Member
General [Line Items]
Stockholders’ Equity (capital deficiency)
Disposal Group Including Discontinued Operation Stockholders Equitycapital Deficiency
Amount of stockholders’ equity (capital deficiency).
Class of Warrant or Right [Table]
Merger Warrants [Member]
Merger Warrants Member
Registered Pre-Funded Warrants [Member]
Registered Pre Funded Warrants Member
Research and development expenses, net [Member]
Research And Development Expenses Net Member
Schedule of Stock-Based Payment Expenses [Line Items]
Basic and Diluted Loss Per Share - Schedule of Diluted Loss Per Share (Details) [Table]
Schedule of Fair Value of Liabilities for Warrants [Line Items]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Government institutions
Government Institutions Current
Government institutions.
Other prepaid expenses
Other Prepaid Expense, Current
Numerator (in Dollars)
Net Income (Loss) Available to Common Stockholders, Basic
Number of shares of common stock outstanding
Weighted Average Number of Shares Outstanding, Diluted, Adjustment
Number of shares upon Fully vested Warrants exercise
Number Of Shares Upon Pre Funded Warrants Exercise
Number of shares upon Pre-Funded Warrants exercise.
Net cash used in operating activities
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
BASIC AND DILUTED LOSS PER SHARE
Earnings Per Share [Text Block]
SUBSEQUENT EVENTS
Subsequent Events [Text Block]
Repricing of warrants under the Inducement Letter Agreements
Repricing Of Warrants Under The Inducement Letter Agreements
The amount of repricing of warrants under the inducement letter agreements.
Principles of Consolidation
Consolidation, Policy [Policy Text Block]
Basic and diluted loss per share
Earnings Per Share, Policy [Policy Text Block]
Fair Value Measurements - Schedule of Fair Value of Liabilities for Warrants [Table]
Fair Value Measurements - Schedule of Fair Value of the Liabilities for the Warrants (Details) [Table]
Expected volatility [Member]
Measurement Input, Price Volatility [Member]
Other
Other
Amount of other asset current.
Employees and related institutions
Employee-related Liabilities
Government institutions
Government Assistance, Liability, Current
Cash and cash equivalents
Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents
Fixed assets
Disposal Group, Including Discontinued Operation, Property, Plant, and Equipment, Current
Current liabilities
Disposal Group, Including Discontinued Operation, Liabilities, Current
Total liabilities and capital deficiency
Disposal Group Including Discontinued Operation Total Liabilities And Capital Deficiency
Amount of total liabilities and capital deficiency.
Schedule Of Outstanding Warrants To Purchase Common Stock Issued To Stockholders Abstract
2021 Registered Direct Offering Warrants [Member]
Two Thousand Twenty One Registered Direct Offering Warrants Member
Private Placement Warrants [Member]
Private Placement Warrants Member
Private Pre-Funded Warrants [Member]
Private Pre Funded Warrants Member
General and administrative [Member]
General And Administrative Member
Stock-based payment expenses
Share-Based Payment Arrangement, Expense
Schedule of Basic and Diluted Net Loss Per Share [Abstract]
Schedule of Other Current Assets [Abstract]
Prepaid insurance
Prepaid Insurance
Numerator:
Net Income (Loss) Attributable to Parent [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION
Significant Accounting Policies [Text Block]
OTHER CURRENT ASSETS
Other Current Assets [Text Block]
STOCKHOLDERS’ EQUITY
Equity [Text Block]
Number of Options, Granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross
Number of Options, Forfeited
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period
Number of Options, Expired
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period
Preferred dividends on Series Y Convertible Preferred Stock (in Dollars)
Preferred dividends on Series Y Convertible Preferred Stock
Amount of preferred dividends on series y convertible preferred stock.
Percentage of cash compensation on gross sales price of common stock
The percentage of cash compensation on gross sales price.
chief executive officer